Cleared Traditional

VARICELLA-ZOSTER-COMPLE FIX ANTIGEN AND NEG CONTRO

K852930 · Microbix Biosystems, Inc. · Microbiology
Nov 1985
Decision
126d
Days
Class 2
Risk

About This 510(k) Submission

K852930 is an FDA 510(k) clearance for the VARICELLA-ZOSTER-COMPLE FIX ANTIGEN AND NEG CONTRO, a Antiserum, Cf, Varicella-zoster (Class II — Special Controls, product code GQX), submitted by Microbix Biosystems, Inc. (Canada, CA). The FDA issued a Cleared decision on November 12, 1985, 126 days after receiving the submission on July 9, 1985. This device falls under the Microbiology review panel. Regulated under 21 CFR 866.3900.

Submission Details

510(k) Number K852930 FDA.gov
FDA Decision Cleared SESE
Date Received July 09, 1985
Decision Date November 12, 1985
Days to Decision 126 days
Submission Type Traditional
Review Panel Microbiology (MI)
Summary —

Device Classification

Product Code GQX — Antiserum, Cf, Varicella-zoster
Device Class Class II — Special Controls
CFR Regulation 21 CFR 866.3900

Similar Devices — GQX Antiserum, Cf, Varicella-zoster

All 10
VARICELLA-ZOSTER VIRUS DIRECT IMMUNOFLUORESCENCE ASSAY
K951799 · Light Diagnostics · Mar 1996
VZV IGM TEST
K911301 · Gull Laboratories, Inc. · Jul 1991
VIRGO(R) VZV-IGG ELISA
K883427 · Electro-Nucleonics, Inc. · Mar 1989
VZV TEST
K875358 · Gull Laboratories, Inc. · Mar 1988
ENZYGNOST ANTI-VZV IGG TEST
K863317 · Behring Diagnostics, Inc. · Apr 1987
FIAX TEST KIT FOR VARICELLA ANTIBODY SEROLOGY
K853540 · Idt, A Division of Whittaker M.A. Bioproducts · Feb 1986